Sue Harnan

All publications

Journal articles

• Cooper K, Nalbant G, Essat M, Harnan S, Wong R, Hamilton J, Asghar US, Battisti NML, Wyld L & Tappenden P (2025) Gene expression profiling tests to guide adjuvant chemotherapy decisions in lymph node-positive early breast cancer: a systematic review. Breast Cancer Research and Treatment.
• Harnan S, Hamilton J, Simpson E, Clowes M, Biz AN, Whyte S, Ren S, Cooper K, Ball A, Benton S , Carten R et al (2024) PP09 Fecal Immunochemical Tests For Patients With Symptoms Suggestive Of Colorectal Cancer: A Systematic Review And Multiple-Threshold Meta-Analysis. International Journal of Technology Assessment in Health Care, 40(S1), S56-S57.
• Biz AN, Stevenson M, Whyte S, Hamilton J, Ren S, Heathcote L, Simpson E, Cooper K, Clowes M, Ball A , Benton S et al (2024) OP15 Cost-Effectiveness Of Quantitative Fecal Immunochemical Tests For Detecting Suspected Colorectal Cancer In The Context Of Colonoscopy Capacity Constraints. International Journal of Technology Assessment in Health Care, 40(S1), S7-S7.
• Harnan S, Hamilton J, Simpson EL, Clowes M, Navega Biz A, Whyte S, Ren K, Cooper K, Abulafi M, Ball A , Benton S et al (2024) MT55 Faecal Immunochemical Tests for Patients in Primary Care With Symptoms of Colorectal Cancer: Systematic Review and Multiple-Threshold Meta-Analysis. Value in Health, 27(12), S496-S496.
• Harnan S, Gittus M, Falzon L, Durkie M, Mandrik L, Ong AC & Fotheringham J (2024) MT41 The Diagnostic Accuracy of Ultrasound and Genetic Tests for the Diagnosis of Autosomal Dominant Polycystic Kidney Disease: A Systematic Mapping Review. Value in Health, 27(12), S493-S493.
• Woods B, Kearns B, Schmitt L, Jankovic D, Rothery C, Harnan S, Hamilton J, Scope A, Ren S, Bojke L , Wilcox M et al (2024) Assessing the Value of New Antimicrobials: Evaluations of Cefiderocol and Ceftazidime-Avibactam to Inform Delinked Payments by the NHS in England. Applied Health Economics and Health Policy, 1-13.
• Cooper K, Campbell F, Harnan S & Sutton A (2023) Association between stress, depression or anxiety and cancer: Rapid review of reviews. Comprehensive Psychoneuroendocrinology. View this article in WRRO
• Poku E, Cooper K, Cantrell A, Harnan S, Sin MA, Zanuzdana A & Hoffman A (2023) Systematic review of time lag between antibiotic use and rise of resistant pathogens among hospitalized adults in Europe. JAC-Antimicrobial Resistance, 5(1). View this article in WRRO
• Rafia R, Martyn-St James M, Harnan S, Metry A, Hamilton J & Wailoo A (2022) A cost-effectiveness analysis of remdesivir for the treatment of hospitalised patients with COVID-19 in England and Wales. Value in Health, 25(5), 761-769. View this article in WRRO
• Poku E, Harnan S, Rooney G, James MM-S, Hernandez M, Schaufler T, Thokala P & Fotheringham J (2022) The relationship between chronic kidney disease–associated pruritus and health-related quality of life: a systematic review. Clinical Kidney Journal, 15(3), 484-499. View this article in WRRO
• Vilaca T, Schini M, Harnan S, Sutton A, Poku E, Allen IE, Cummings SR & Eastell R (2020) The risk of hip and non-vertebral fractures in type 1 and type 2 diabetes: A systematic review and meta-analysis update. Bone, 137. View this article in WRRO
• Vilaca T, Salam S, Schini M, Harnan S, Sutton A, Poku E, Allen IE, Cummings SR & Eastell R (2020) Risks of hip and nonvertebral fractures in patients with CKD G3a-G5D: a systematic review and meta-analysis. American Journal of Kidney Diseases. View this article in WRRO
• Schini M, Vilaca T, Poku E, Harnan S, Sutton A, Allen IE, Cummings SR & Eastell R (2020) The risk of hip and non-vertebral fractures in patients with Parkinson's disease and parkinsonism : a systematic review and meta-analysis. Bone, 132. View this article in WRRO
• Harnan S, Tappenden P, Cooper K, Stevens J, Bessey A, Rafia R, Ward S, Wong R, Stein RC & Brown J (2019) Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer: a systematic review and economic analysis. Health Technology Assessment, 23(30). View this article in WRRO
• Mukuria C, Rowen D, Harnan S, Rawdin A, Wong R, Ara R & Brazier J (2019) An Updated Systematic Review of Studies Mapping (or Cross-Walking) Measures of Health-Related Quality of Life to Generic Preference-Based Measures to Generate Utility Values. Applied Health Economics and Health Policy, 17(3), 295-313. View this article in WRRO
• Rafia R, Pandor A, Davis S, Stevens JW, Harnan S, Clowes M, Sorour Y & Cutting R (2018) Obinutuzumab with Bendamustine for Treating Follicular Lymphoma Refractory to Rituximab: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics, 36(10), 1143-1151. View this article in WRRO
• Phang Romero Casas C, Martyn-St James M, Hamilton J, Marinho DS, Castro R & Harnan S (2018) Rapid diagnostic test for antenatal syphilis screening in low-income and middle-income countries: a systematic review and meta-analysis. BMJ Open, 8(2), e018132-e018132. View this article in WRRO
• Cree IA, Uttley L, Buckley Woods H, Kikuchi H, Reiman A, Harnan S, Whiteman BL, Philips ST, Messenger M, Cox A , Teare D et al (2017) The evidence base for circulating tumour DNA blood-based biomarkers for the early detection of cancer: a systematic mapping review. BMC Cancer, 17, 697-697. View this article in WRRO
• Bermejo I, Stevenson M, Cooper K, Harnan S, Hamilton J, Clowes M, Carroll C, Harrison T & Saha S (2017) Mepolizumab for Treating Severe Eosinophilic Asthma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. Pharmacoeconomics. View this article in WRRO
• Harnan SE, Essat M, Gomersall T, Tappenden P, Pavord I, Everard M & Lawson R (2017) Exhaled nitric oxide in the diagnosis of asthma in adults: a systematic review. Clinical and Experimental Allergy, 47(3), 410-429. View this article in WRRO
• Tappenden P, Harnan S, Ren S, Thokala P, Wong R, Mukuria C, Green C, Pledge S & Tidy J (2017) Olaparib for Maintenance Treatment of BRCA 1 or 2 Mutated, Relapsed, Platinum-Sensitive Ovarian, Fallopian Tube and Peritoneal Cancer in People Whose Relapsed Disease has Responded to Platinum-Based Chemotherapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics, 35(1), 97-109. View this article in WRRO
• Rafia R, Scope A, Harnan S, Stevens JW, Stevenson M & Lobo A (2016) Vedolizumab for Treating Moderately to Severely Active Crohn’s Disease After Prior Therapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics, 34(12), 1241-1253. View this article in WRRO
• Uttley L, Whiteman BL, Woods HB, Harnan S, Philips ST & Cree IA (2016) Building the Evidence Base of Blood-Based Biomarkers for Early Detection of Cancer: A Rapid Systematic Mapping Review. EBioMedicine. View this article in WRRO
• Harnan S, Ren S, Gomersall T, hock , sutton A, Dhanasiri S & Kulasekararaj A (2016) Association between Transfusion Status and Overall Survival in Patients with Myelodysplastic Syndromes: A Systematic Literature Review and Meta-Analysis. Acta Haematologica, 136(1), 23-42. View this article in WRRO
• Gomersal T, Harnan S, Essat M, Tappenden P, Wong R, Lawson R, Pavord I & Everard ML (2016) A systematic review of fractional exhaled nitric oxide in the routine management of childhood asthma. Pediatric Pulmonology, 51(3), 316-328.
• Essat M, Harnan S, Gomersall T, Tappenden P, Wong R, Pavord I, Lawson R & Everard M (2016) Fractional exhaled nitric oxide for the management of asthma in adults: a systematic review. European Respiratory Society, 47(3), 751-768. View this article in WRRO
• Pickering A, Harnan S, Cooper K, Sutton A, Mason S & Nicholl J (2016) Acute ischaemic stroke patients – direct admission to a specialist centre or initial treatment in a local hospital? A systematic review. Journal of Health Services Research & Policy, 21(1), 51-60.
• Harnan SE, Cooper K, Jones SL & Jones E (2015) Pruning and prioritising: a case study of a pragmatic method for managing a rapid systematic review with limited resources. Evidence & Policy: A Journal of Research, Debate and Practice, 11(4), 589-601. View this article in WRRO
• Pickering A, Cooper K, Harnan S, Sutton A, Mason S & Nicholl J (2015) Impact of prehospital transfer strategies in major trauma and head injury. Journal of Trauma and Acute Care Surgery, 78(1), 164-177. View this article in WRRO
• Whyte S & Harnan S (2014) Effectiveness and cost-effectiveness of an awareness campaign for colorectal cancer: a mathematical modeling study.. Cancer Causes Control, 25(6), 647-658. View this article in WRRO
• Meng Y, Squires H, Stevens JW, Simpson E, Harnan S, Thomas S, Michaels J, Stansby G & O'Donnell ME (2014) Cost-effectiveness of cilostazol, naftidrofuryl oxalate, and pentoxifylline for the treatment of intermittent claudication in people with peripheral arterial disease.. Angiology, 65(3), 190-197.
• Tappenden P, Harnan S, Uttley L, Mildred M, Walshaw M, Taylor C & Brownlee K (2014) The Cost Effectiveness of Dry Powder Antibiotics for the Treatment of Pseudomonas aeruginosa in Patients with Cystic Fibrosis. PHARMACOECONOMICS, 32(2), 159-172.
• Tappenden P, Harnan S, Uttley L, Mildred M, Carroll C & Cantrell A (2013) Colistimethate sodium powder and tobramycin powder for inhalation for the treatment of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis: systematic review and economic model.. Health Technol Assess, 17(56), v-181.
• Uttley L, Harnan S, Cantrell A, Taylor C, Walshaw M, Brownlee K & Tappenden P (2013) Systematic review of the dry powder inhalers colistimethate sodium and tobramycin in cystic fibrosis.. Eur Respir Rev, 22(130), 476-486.
• Stevens JW, Simpson E, Harnan S, Squires H, Meng Y, Thomas S, Michaels J & Stansby G (2013) Authors' reply: systematic review of the efficacy of cilostazol, naftidrofuryl oxalate and pentoxifylline for the treatment of intermittent claudication (Br J Surg 2012; 99: 1630-1638).. Br J Surg, 100(13), 1838-1839.
• Ward S, Scope A, Rafia R, Pandor A, Harnan S, Evans P & Wyld L (2013) Gene expression profiling and expanded immunohistochemistry tests to guide the use of adjuvant chemotherapy in breast cancer management: a systematic review and cost-effectiveness analysis.. Health Technol Assess, 17(44), 1-302. View this article in WRRO
• Stevens JW, Simpson E, Harnan S, Squires H, Meng Y, Thomas S, Michaels J & Stansby G (2012) Systematic review of the efficacy of cilostazol, naftidrofuryl oxalate and pentoxifylline for the treatment of intermittent claudication. British Journal of Surgery, 99(12), 1630-1638.
• Pandor A, Harnan S, Goodacre S, Pickering A, Fitzgerald P & Rees A (2012) Diagnostic accuracy of clinical characteristics for identifying CT abnormality after minor brain injury: a systematic review and meta-analysis.. J Neurotrauma, 29(5), 707-718.
• Squires H, Simpson E, Meng Y, Harnan S, Stevens JW, Wong R, Thomas S, Michaels J & Stansby G (2011) A systematic review and economic evaluation of cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for the treatment of intermittent claudication in people with peripheral arterial disease. Health Technology Assessment, 15(40).
• Harnan SE, Cooper KL, Meng Y, Ward SE, Fitzgerald P, Papaioannou D, Ingram C, Lorenz E, Wilkinson ID & Wyld L (2011) Magnetic resonance for assessment of axillary lymph node status in early breast cancer: a systematic review and meta-analysis.. Eur J Surg Oncol, 37(11), 928-936. View this article in WRRO
• Pickering A, Goodacre S, Pandor A, Harnan S, Holmes M & Fitzgerald P (2011) Diagnosis and management of minor head injury in the UK. Journal of Paramedic Practice, 3(8), 418-423.
• Pandor A, Goodacre S, Harnan S, Holmes M, Pickering A, Fitzgerald P, Rees A & Stevenson M (2011) Diagnostic management strategies for adults and children with minor head injury: a systematic review and an economic evaluation.. Health Technol Assess, 15(27), 1-202.
• Harnan SE, Pickering A, Pandor A & Goodacre SW (2011) Clinical decision rules for adults with minor head injury: a systematic review.. J Trauma, 71(1), 245-251.
• Cooper KL, Harnan S, Meng Y, Ward SE, Fitzgerald P, Papaioannou D, Wyld L, Ingram C, Wilkinson ID & Lorenz E (2011) Positron emission tomography (PET) for assessment of axillary lymph node status in early breast cancer: A systematic review and meta-analysis.. Eur J Surg Oncol, 37(3), 187-198.
• Cooper KL, Meng Y, Harnan S, Ward SE, Fitzgerald P, Papaioannou D, Wyld L, Ingram C, Wilkinson ID & Lorenz E (2011) Positron emission tomography (PET) and magnetic resonance imaging (MRI) for the assessment of axillary lymph node metastases in early breast cancer: systematic review and economic evaluation.. Health Technol Assess, 15(4), iii-134.
• Pickering A, Harnan S, Fitzgerald P, Pandor A & Goodacre S (2011) Clinical decision rules for children with minor head injury: A systematic review. Archives of Disease in Childhood, 96(5), 414-421.
• Meng Y, Ward S, Cooper K, Harnan S & Wyld L (2011) Cost-effectiveness of MRI and PET imaging for the evaluation of axillary lymph node metastases in early stage breast cancer.. Eur J Surg Oncol, 37(1), 40-46.
• Harnan S, Hamilton J, Simpson E, Clowes M, Navega Biz A, Whyte S, Ren S, Cooper K, Abulafi M, Ball A , Beton S et al () Faecal Immunochemical Tests For Patients With Symptoms Suggestive Of Colorectal Cancer: An Updated Systematic Review And Multiple-Threshold Meta-Analysis of Diagnostic Test Accuracy Studies. Colorectal Disease.
• Harnan S, Kearns B, Scope A, Schmitt L, Jankovic D, Hamilton J, Srivastava T, Hill H, Ku CC, Ren S , Rothery C et al () Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model. Health Technology Assessment, 1-230.
• Cooper K, Nalbant G, Sutton A, Harnan S, Thokala P, Chilcott J, McNeill A & Bessey A () Systematic Review of Presymptomatic Treatment for Spinal Muscular Atrophy. International Journal of Neonatal Screening, 10(3), 56-56.
• Cooper K, Nalbant G, Sutton A, Harnan S, Thokala P, Chilcott J, McNeill A & Bessey A () Systematic Review of Newborn Screening Programmes for Spinal Muscular Atrophy. International Journal of Neonatal Screening, 10(3), 49-49.
• Woods B, Schmitt L, Jankovic D, Kearns B, Scope A, Ren S, Srivastava T, Ku CC, Hamilton J, Rothery C , Bojke L et al () Cefiderocol for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model. Health Technology Assessment, 1-238.
• Harnan SE, Tappenden P, Essat M, Gomersall T, Minton J, Wong R, Pavord I, Everard M & Lawson R () Measurement of exhaled nitric oxide concentration in asthma: a systematic review and economic evaluation of NIOX MINO, NIOX VERO and Nobreath. Health Technology Assessment, 19(82), 1-330. View this article in WRRO

Conference proceedings papers

• Vilaca T, Schini M, Harnan S, Poku E, Cummings SR & Eastell R (2020) SUN-622 The risk of hip and non-vertebral fractures in diabetes : a systematic review and meta-analysis update. Journal of the Endocrine Society, Vol. 4(Supplement_1). San Francisco, CA, USA, 28 March 2020 - 31 March 2020. View this article in WRRO
• Schini M, Vilaca T, Poku E, Harnan S, Sutton A, Allen IE, Cummings S & Eastell R (2020) THE RISK OF HIP AND NON-VERTEBRAL FRACTURES IN PARKINSON'S DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS. OSTEOPOROSIS INTERNATIONAL, Vol. 31(SUPPL 1) (pp S55-S55)
• Schini M, Vilaca T, Eastell R, Harnan S, Sutton A, Poku E & Cummings S (2019) The Risk of Hip and Non-Vertebral Fractures in Parkinson's Disease: A Systematic Review and Meta-Analysis. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 34 (pp 103-103)
• Vilaca T, Salam S, Eastell R, Schini M, Harnan S, Sutton A, Poku E & Cummings S (2019) The Risk of Hip and Non-Vertebral Fractures in Chronic Kidney Disease: A Systematic Review and Meta-Analysis. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 34 (pp 25-25)
• Harnan S, Essat M, Gomersall T, Tappenden P, Wong R, Lawson R, Pavord I & Everard M (2015) Exhaled Nitric Oxide For The Diagnosis Of Asthma In Adults And Children: A Systematic Review. Value in Health, Vol. 18(7) (pp A345-A345)
• Harnan S, Ren S, Gomersall T, Everson-Hock E, Sutton A, Dhanasiri S & Kulasekararaj A (2014) Systematic Review and Meta-Analysis of the Association Between Transfusion Independence (TI) and Overall Survival (OS) in Patients (pts) with Myelodysplastic Syndromes (MDS). Blood, Vol. 124(21) (pp 1934-1934)
• Tappenden P, Harnan S, Uttley L, Mildred M, Taylor CJ, Brownlee K & Walshaw M (2013) The Cost-Effectiveness of Dry Powder Antibiotics for the Treatment of Pseudomonas Aeruginosa in Patients with Cystic Fibrosis. Value in Health, Vol. 16(7) (pp A372-A372)
• Harnan SE, Uttley L, Cantrell A, Taylor CJ, Walshaw M, Brownlee K & Tappenden P (2013) SYSTEMATIC REVIEW OF COLISTIMETHATE SODIUM DRY POWDER AND TOBRAMYCIN DRY POWDER ANTIBIOTICS FOR PSEUDOMONAS AERUGINOSA LUNG INFECTION IN CYSTIC FIBROSIS. VALUE IN HEALTH, Vol. 16(7) (pp A367-A367)
• Meng Y, Squires H, Stevens JW, Simpson E, Harnan S, Thomas S, Michaels J, Stansby G & O'Donnell M (2012) COST-EFFECTIVENESS OF CILOSTAZOL, NAFTIDROFURYL OXALATE, PENTOXIFYLLINE AND INOSITOL NICOTINATE FOR THE TREATMENT OF INTERMITTENT CLAUDICATION IN PEOPLE WITH PERIPHERAL ARTERIAL DISEASE IN THE UK. VALUE IN HEALTH, Vol. 15(7) (pp A633-A633)
• Pandor A, Harnan SE, Goodacre SW, Pickering A, Fitzgerald P & Rees AC (2011) DIAGNOSTIC ACCURACY OF CLINICAL CHARACTERISTICS FOLLOWING MINOR HEAD INJURY: A SYSTEMATIC REVIEW AND META-ANALYSIS. VALUE IN HEALTH, Vol. 14(7) (pp A245-A245)
• Harnan SE, Pickering A, Pandor A & Goodacre SW (2011) CLINICAL DECISION RULES FOR ADULTS WITH MINOR HEAD INJURY: A SYSTEMATIC REVIEW. VALUE IN HEALTH, Vol. 14(7) (pp A244-A244)
• Harnan SE, Jorgensen A, Tsuchiya A, Goyder L & Woods HB (2011) TOWARDS COST-EFFECTIVENESS ANALYSIS OF THE HEALTH AND WELLBEING BENEFITS OF URBAN GREEN SPACE: A MAPPING REVIEW. VALUE IN HEALTH, Vol. 14(7) (pp A343-A343)
• Pickering A, Fitzgerald P, Harnan SE, Pandor A & Goodacre SW (2011) BIOCHEMICAL MARKERS FOR THE IDENTIFICATION OF INTRACRANIAL INJURY FOLLOWING MINOR HEAD INJURY: A SYSTEMATIC REVIEW AND META-ANALYSIS. VALUE IN HEALTH, Vol. 14(7) (pp A244-A244)
• White S, Mason S, Parker A, Harnan S, Davis B, ChessWilliams R & Woolf A (1997) alpha(1B)-adrenoceptor affinity and density differentiated and undifferentiated mouse glomerular mesangial cells.. J AM SOC NEPHROL, Vol. 8 (pp A1432-A1432)
• BLEAKMAN D, PEARSON K, HARNAN S, KAMBOJ R & SCHOEPP D (1995) EFFECTS OF LY293558 AND NBQX ON GLUTAMATE-RECEPTOR RESPONSES IN RAT CEREBELLAR PURKINJE NEURONS AND HEK293 CELLS EXPRESSING THE HUMAN GLUR6 GLUTAMATE-RECEPTOR. BRIT J PHARMACOL, Vol. 115 (pp P112-P112)

Reports

• Leaviss J, Harnan S, Pandor A & Cantrell A (2022) Newborn screening for congenital adrenal hyperplasia. External review against programme appraisal criteria for the UK National Screening Committee
• Harnan S, Kearns B, Scope A, Schmitt1 L, Jankovic1 D, Hamilton J, Wong R, Srivastava T, Hill H, Chang Ku C , Ren K et al (2021) Final report for the technology evaluation of ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections.
• Ara R, Duarte A, Harnan S, Leaviss J, Palmer S, Sculpher M & Brazier JE (2015) Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix J - Dementia. View this article in WRRO
• Ara R, Duarte A, Harnan S, Leaviss J, Palmer S, Sculpher M & Brazier JE (2015) Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix K - Cardiovascular. View this article in WRRO
• Ara R, Duarte A, Harnan S, Leaviss J, Palmer S, Sculpher M & Brazier JE (2015) Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix H - Psychological Therapies View this article in WRRO
• Ara R, Duarte A, Harnan S, Leaviss J, Palmer S, Sculpher M & Brazier JE (2015) Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix I - Schizophrenia View this article in WRRO
• Ara R, Duarte A, Harnan S, Leaviss J, Palmer S, Sculpher M & Brazier JE (2015) Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix E - Diabetes View this article in WRRO
• Ara R, Duarte A, Harnan S, Leaviss J, Palmer S, Sculpher M & Brazier JE (2015) Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix G - Head and Neck Cancer. View this article in WRRO
• Ara , Duarte A, Harnan S, Leaviss J, Palmer S, Sculpher M & Brazier JE (2015) Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix D - Epilepsy View this article in WRRO
• Ara R, Duarte A, Harnan S, Leaviss J, Palmer S, Sculpher M & Brazier JE (2015) . Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix F - Bowel Cancer. View this article in WRRO
• Ara R, Duarte A, Harnan S, Leaviss J, Palmer S, Sculpher M & Brazier JE (2015) Supporting the collection patient reported outcome measures in the National Clinical Audits for assessing costeffectiveness Work Package 1. What patient reported outcome measures should be used in the 13 health conditions specified in the 2013/14 National Clinical Audit programme? APPENDIX C, INFLAMMATORY BOWEL DISEASE View this article in WRRO
• Ara R, Duarte A, Harnan S, Leaviss J, Palmer S, Sculpher M & Brazier JE (2015) Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. View this article in WRRO

Posters

• Pickering A, Harnan S, Pandor A, Fitzgerald P & Goodacre S (2010) Clinical Decision Rules for children with minor head injury: A systematic review. European Society of Emergency Medicine,(EuSEM) Stockholm.
• Pickering A, Harnan S & Goodacre S Diagnostic accuracy of individual characteristics following minor head injury in children: A systematic review.
• Pickering A, Harnan S, Pandor A & Goodacre S A systematic review of Clinical Decision Rules in the management of adult minor head injury.
• Carroll C, Papaioannou D & Harnan S Surgical interventions for the primary prophylaxis of retinal detachment in Stickler Syndrome: a systematic review.
• Harnan S, Cooper K, Meng Y, Ward S, Fitzgerald P, Papaioannou D, Wyld L, Ingram C, Wilkinson I & Lorenz E Magnetic resonance imaging (MRI) for assessment of axillary lymph node metastases in breast cancer: systematic review.
• Harnan S, Pickering A, Pandor A & Goodacre S Clinical decision rules for adults with minor head injury: a systematic review.
• Harnan S, Jorgensen A, Tsuchiya A, Goyder E & Woods H Towards cost-effectiveness analysis of the health and wellbeing benefits of urban green space: a mapping review.
• Pickering A, Fitzgerald P, Harnan S, Pandor A & Goodacre S The role of biochemical markers in the identification of intracranial pathology following minor head injury: a systematic review and meta-analysis.
• Pandor A, Harnan S, Goodacre S, Pickering A & Rees A Diagnostic accuracy of clinical characteristics following minor head injury: a systematic review and meta-analysis.
• Pickering A, Harnan S, Pandor A & Goodacre S Clinical Decision Rules for children with minor head injury: A systematic review.
• Harnan S, Essat M, Gomersall T, Tappenden P, Wong R, Lawson R, Pavord I & Everard M Exhaled nitric oxide for the diagnosis of asthma in children and adults: a systematic review.
• Pandor A, Harnan S, Goodacre S, Pickering A, Fitzgerald P & Rees A Diagnostic accuracy of clinical characteristics following minor head injury: a systematic review and meta-analysis.